Saúde Pública/Medicina Humanitária
Não, pessoas vacinadas não são “tão capazes” de disseminar coronavírus quanto pessoas não vacinadas.
27 Set, 2021 | 12:46h
Comentário no Twitter
“Vaccinated people are just as likely to spread the coronavirus.”
This isn't true. But some people — even some very smart people — mistakenly believe this.
Dr. @Craig_A_Spencer explains here why, in this really good piece from @TheAtlantic.https://t.co/9D1dngt3oG
— Paul Sax (@PaulSaxMD) September 23, 2021
Como os dados dos pacientes embasam a pesquisa sobre COVID-19 – “Rastrear o vírus SARS-CoV-2, desenvolver tratamentos e testar vacinas teve como base o acesso a dados de saúde de milhões de pessoas. Esta preciosidade massiva poderia ser usada para compreender outras doenças, mas nem todos estão convencidos disso.”
27 Set, 2021 | 12:44hHow patient data underpin COVID-19 research – Nature
Vacinas contra COVID-19 e variantes do SARS-CoV-2.
27 Set, 2021 | 12:43hCOVID-19 vaccines: Keeping pace with SARS-CoV-2 variants – Cell
Comentário no Twitter
COVID-19 #vaccines: Keeping pace with SARS-CoV-2 #variants. Timely commentary on understanding #immune correlates and laboratory findings in the context vaccine efficacy from @mugecevik @NathanGrubaugh @VirusesImmunity @p_openshaw https://t.co/o4GoChq5RM #COVID19 #SARSCoV2 pic.twitter.com/UuWqWa711K
— Sri Baqri (Narasimhan) (@Sri_Baqri) September 17, 2021
Estudo randomizado de fase 1/2 | Segurança e imunogenicidade de vacina inativada contra COVID-19 (BBIBP-CorV) em crianças e adolescentes de 3 a 17 anos de idade.
27 Set, 2021 | 12:11hConteúdo relacionado: Phase 1/2 RCT: CoronaVac is well tolerated and safe and induces strong humoral responses in children and adolescents aged 3–17 years.
Coleção especial Cochrane | Suspensão dos cuidados de saúde de baixo valor: priorização dos recursos na era da pandemia de COVID-19.
27 Set, 2021 | 12:10hEditorial: Making wise choices about low‐value health care in the COVID‐19 pandemic – Cochrane Library
Comentário: Choosing health care wisely when resources are scarce – Evidently Cochrane
Comentários no Twitter
📰Our new editorial @cochranecollab: Making wise choices about low‐value health care in the COVID‐19 pandemic👉https://t.co/qABVg7emRi
Linked Special Collection on low-value care: https://t.co/fstV8P8OQS#FreeAccess pic.twitter.com/h9KZGUm2kp
— Juan Franco 🏳️🌈 (@juan_francomd) September 22, 2021
Sadly, some medical interventions are in use despite evidence against them. With @Cochrane_SH, we have published a Special Collection of Cochrane reviews of Low Value Care interventions and described the issue in an Editorial. We cannot afford wasted HC. https://t.co/PXUhaMZud2
— Karsten Juhl Jørgensen (@KarstenJuhl) September 22, 2021
“Não é um jogo de soma zero”: compartilhar vacinas é do interesse de todos os países.
27 Set, 2021 | 12:06h‘Not a zero-sum game’: Sharing vaccines is in countries’ best interests – YaleNews
Artigo original: National interest may require distributing COVID-19 vaccines to other countries – Scientific Reports
Comentário no Twitter
"when US has reached the threshold for domestic herd immunity, it would be optimal to donate doses to other countries, as this would allow for a sharp reduction in the inflow of infected individuals from abroad"
– Modeling by @SaadOmer3, @amynmalik & co https://t.co/NFfp39tde6— Ahmed Mushfiq Mobarak (@mushfiq_econ) September 16, 2021
Nova diretriz global da OMS sobre a qualidade do ar visa a salvar milhões de vidas da poluição atmosférica.
27 Set, 2021 | 12:03hComunicado de imprensa: New WHO Global Air Quality Guidelines aim to save millions of lives from air pollution – World Health Organization
Diretriz original: WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide
Resumo executivo: WHO global air quality guidelines: particulate matter (PM2.5 and PM10), ozone, nitrogen dioxide, sulfur dioxide and carbon monoxide
Comentários:
Millions of deaths could be avoided under new air quality guidelines, WHO says – CNN
WHO slashes guideline limits on air pollution from fossil fuels – The Guardian
OMS lança novo compêndio de tecnologias inovadoras de saúde para COVID-19 e outras doenças prioritárias.
27 Set, 2021 | 12:02h[Comunicado de imprensa – ainda não publicado] J&J afirma que dose de reforço depois de 2 meses propiciou 75% de proteção contra COVID-19 moderada a grave globalmente, sendo 94% desses casos nos EUA.
27 Set, 2021 | 11:39hComunicado de imprensa: Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.
Comentários:
Johnson & Johnson says additional dose boosts Covid vaccine efficacy – STAT
J&J booster 94% effective against severe COVID, company says – CIDRAP
Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds – CNN
Comentários no Twitter
(fio – clique para saber mais)
📍BREAKING—At last—new data on 2-doses of Johnson & Johnson's #vaccine (doses 56 days apart) is 94% effective against symptomatic #COVID19, thus comparable to Moderna/Pfizer. And 100% effective against severe COVID. Booster for 1 dose works well too. 🧵https://t.co/3nPkodOjuG pic.twitter.com/DizjWt9NYX
— Eric Feigl-Ding (@DrEricDing) September 21, 2021
(fio – clique para saber mais)
First press released results out for the double-dose J&J vax trial, ENSEMBLE 2. With 2 months between doses, efficacy against moderate to severe/critical increased – didn't provide overall efficacy data though. Adverse reactions similar to 1st dose …1/n https://t.co/BmBVtLvEaW
— Hilda Bastian, PhD (@hildabast) September 21, 2021
Perspectiva | Desculpe, mas uma infecção por coronavírus pode não ser o suficiente para proteger você – “Qualquer um que prefira ter COVID-19 do que se vacinar está fazendo uma aposta dupla: que a imunidade se mantenha, e os sintomas, não.”
27 Set, 2021 | 11:35hSorry, a Coronavirus Infection Might Not Be Enough to Protect You – The Atlantic